drugset / Trial / NCT03967847

Oral Ketorolac for Arthroscopic Rotator Cuff Repair

NCT03967847

Phase 3 Completed 44 enrolled University Hospitals Cleveland Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following arthroscopic rotator cuff repair. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following arthroscopic rotator cuff repair.

Timeline

Start
2019-02-11
Primary completion
2020-10-14
Completion
2021-05-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified Oral

Indications